What's new

Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised

Mar 27, 2025 - 17:41
 0
Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised
Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Laventair Ellipta (pre...

Next Article

F-35, other ‘options’ on table during Portugal’s F-16 replacement analysis: Air ...

Related Posts

PSUSA/00002163/202407

PSUSA/00002163/202407

Feb 14, 2025  0

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 24, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 20, 2025  0

Human medicines European public assessment report (EPAR): Polivy, polatuzumab vedotin, Date of authorisation: 16/01/2020, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 21, 2025  0